Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHD
THURSDAY, Nov. 30, 2023 -- The presence of psychiatric comorbidity in young patients with attention-deficit/hyperactivity disorder (ADHD) is associated with a higher risk for being diagnosed with schizophrenia, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 30, 2023 Category: Pharmaceuticals Source Type: news
Deep-Learning Model Shows Promise for ADHD Diagnosis in Teens
(MedPage Today) -- CHICAGO -- An artificial intelligence (AI) deep-learning model pinpointed significant differences in nine brain white matter tracts in adolescents with attention deficit-hyperactivity disorder (ADHD), researchers reported here... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 30, 2023 Category: Neurology Source Type: news
Before ADHD Diagnosis, Youth Twice as Likely to Have Used Health Care Services
WEDNESDAY, Nov. 29, 2023 -- Two years before attention-deficit/hyperactivity disorder (ADHD) diagnosis, youth with ADHD are twice as likely to use health care services as youth without the condition, according to a study published online Oct. 30 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2023 Category: Pharmaceuticals Source Type: news
People with ADHD in the workplace may get'passed over for promotions' and struggle to climb the corporate ladder, a clinical psychologist said
None People with ADHD may face some barriers to success in corporate environments, a psychologist told Business Insider. • None Those with the condition often struggle with "inconsistency around efficiency," Dr. Scott Kollins said. • None Consequences may include not getting promoted, poor…#scottkollins #akiliinteractive #tiktok #timeblindness #kollins #trefren #bryanwatkins #wean #omnifocus #watkins (Source: Reuters: Health)
Source: Reuters: Health - November 29, 2023 Category: Consumer Health News Source Type: news
AI-DWI shows differences in brains of children with, without ADHD
CHICAGO -- AI-assisted diffusion-weighted imaging (DWI) shows differences in the brains of children with and without attention-deficit/hyperactivity disorder (ADHD), a study presented November 29 at the 2023 RSNA annual meeting has found. In his presentation, Justin Huynh from the University of California, San Francisco found that the deep-learning model revealed significant differences in nine brain white matter tracts in children with ADHD. “These differences in MRI signatures in individuals with ADHD have never been seen before at this level of detail,” Huynh said. “In general, the abnormalities seen in the nine...
Source: AuntMinnie.com Headlines - November 29, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties MRI Neuroradiology RSNA 2023 Source Type: news
Long-Term Exposure to ADHD Meds Linked to Increased Risk for CVD
MONDAY, Nov. 27, 2023 -- Long-term exposure to attention-deficit/hyperactivity disorder (ADHD) medications is associated with an increased risk for cardiovascular disease (CVD), especially hypertension, according to a study published online Nov. 22... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 27, 2023 Category: Pharmaceuticals Source Type: news
Long-Term Use of ADHD Meds and CVD Risk: New Data Long-Term Use of ADHD Meds and CVD Risk: New Data
Despite previous mixed findings, results of a large Swedish study show an increased risk for CVD with long-term use of medications, especially stimulants, to treat attention-deficit/hyperactivity disorder.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - November 22, 2023 Category: Psychiatry Tags: Psychiatry News Source Type: news
Longer Use of ADHD Meds May Boost Heart Risk
(MedPage Today) -- Longer use of attention deficit-hyperactivity disorder (ADHD) medication was associated with an increased risk of cardiovascular disease, particularly hypertension and arterial disease, a nested case-control study from Sweden... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 22, 2023 Category: Psychiatry Source Type: news
Positive KarXT Blood Pressure Data; ADHD Manufacturing Cover-Up? 'Profound Autism'
(MedPage Today) -- Karuna Therapeutics released reassuring phase Ib data mitigating blood pressure concerns with its investigational psychiatric drug KarXT; the novel agent is under review with the FDA for an indication in schizophrenia.
A Massachusetts... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 22, 2023 Category: Psychiatry Source Type: news
Social media addiction in adolescents and it's relationship with psychopathology - Şireli Bingöl, Colak M.
OBJECTIVES:
The aim of this study is to investigate the relationship between social media addiction in adolescents and depression, social anxiety and level of attention deficit hyperactivity disorder (ADHD).
Materials and Methods:
Participants are ... (Source: SafetyLit)
Source: SafetyLit - November 21, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Texas Sues Pfizer Over Tainted Children's Drugs
Texas Sues Pfizer Over Tainted Children's Drugs Texas Attorney General Ken Paxton has sued Pfizer and Tris Pharma "for defrauding the Texas Medicaid program by providing adulterated pharmaceutical drugs to Texas children." Specifically, Pfizer's ADHD drug "Quillivant XR" was "knowingly…#kenpaxton #pfizer #trispharma #texasmedicaid #medicaid #texasag #quillivant #breakingtodayi #defendants #tylerdurden (Source: Reuters: Health)
Source: Reuters: Health - November 21, 2023 Category: Consumer Health News Source Type: news
Texas AG sues Pfizer over quality-control lapses in kids' ADHD drug
Texas Attorney General Ken Paxton accused Pfizer and its supplier Tris Pharma of providing children's ADHD medicine that it knew might be ineffective to the state's Medicaid insurance program for low-income people, in a lawsuit unsealed on Monday. The lawsuit, filed in Harrison County, Texas…#kenpaxton #pfizer #trispharma #medicaid #harrisoncounty #texasdistrictcourt #quillivant #tarikahmed #manhattan #southerndistrict (Source: Reuters: Health)
Source: Reuters: Health - November 21, 2023 Category: Consumer Health News Source Type: news
Psychometric properties of the Hungarian childhood trauma questionnaire short form and its validity in patients with adult attention-deficit hyperactivity disorder or borderline personality disorder - Ken ézlöi E, Csernela E, Nemoda Z, Lakatos K, Czéh B, Unoka ZS, Simon M, Réthelyi JM.
BACKGROUND: Compelling evidence supports the role of childhood traumatization in the etiology of psychiatric disorders, including adult attention-deficit hyperactivity disorder (aADHD) and borderline personality disorder (BPD). The aim of this study was to... (Source: SafetyLit)
Source: SafetyLit - November 20, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Suicidality and nonsuicidal self-injury in females diagnosed with attention-deficit hyperactivity disorder - a narrative review - Todzia-Korna ś A, Szczegielniak A, Gondek TM.
PURPOSE OF REVIEW: Attention deficit hyperactivity disorder (ADHD) is a common psychiatric disorder and is associated with an increased risk of suicidal behavior, especially in females. The differences in the presentation of ADHD in females, factors contri... (Source: SafetyLit)
Source: SafetyLit - November 18, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
US Limit on a Key ADHD Drug Is Worsening Shortages, Group Says
(Source: Reuters: Health)
Source: Reuters: Health - November 17, 2023 Category: Consumer Health News Source Type: news
